JP5374491B2 - 骨折および骨欠損の処置のためのハーブ製剤 - Google Patents

骨折および骨欠損の処置のためのハーブ製剤 Download PDF

Info

Publication number
JP5374491B2
JP5374491B2 JP2010502115A JP2010502115A JP5374491B2 JP 5374491 B2 JP5374491 B2 JP 5374491B2 JP 2010502115 A JP2010502115 A JP 2010502115A JP 2010502115 A JP2010502115 A JP 2010502115A JP 5374491 B2 JP5374491 B2 JP 5374491B2
Authority
JP
Japan
Prior art keywords
bone
treatment
year old
herbal
weeks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010502115A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523563A (ja
JP2010523563A5 (https=
Inventor
アビラ，アルフレド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2010523563A publication Critical patent/JP2010523563A/ja
Publication of JP2010523563A5 publication Critical patent/JP2010523563A5/ja
Application granted granted Critical
Publication of JP5374491B2 publication Critical patent/JP5374491B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
JP2010502115A 2007-04-02 2008-04-01 骨折および骨欠損の処置のためのハーブ製剤 Expired - Fee Related JP5374491B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90745107P 2007-04-02 2007-04-02
US60/907,451 2007-04-02
PCT/US2008/004220 WO2008123970A1 (en) 2007-04-02 2008-04-01 Herbal formulation for the treatment of bone fractures and osseous defects

Publications (3)

Publication Number Publication Date
JP2010523563A JP2010523563A (ja) 2010-07-15
JP2010523563A5 JP2010523563A5 (https=) 2011-05-19
JP5374491B2 true JP5374491B2 (ja) 2013-12-25

Family

ID=39794790

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010502115A Expired - Fee Related JP5374491B2 (ja) 2007-04-02 2008-04-01 骨折および骨欠損の処置のためのハーブ製剤

Country Status (4)

Country Link
US (2) US7871648B2 (https=)
JP (1) JP5374491B2 (https=)
MX (1) MX2009010713A (https=)
WO (1) WO2008123970A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2640706B1 (en) 2010-11-15 2017-03-01 Bayer Intellectual Property GmbH N-aryl pyrazole(thio)carboxamides
CN111084780A (zh) * 2020-01-09 2020-05-01 昆明医科大学 老鹳草素在制备治疗骨质疏松合并骨折的药物中的用途
RU2758135C1 (ru) * 2021-01-25 2021-10-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ лечения больных с замедленной консолидацией переломов костей нижней трети голени

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0789862A (ja) * 1990-05-29 1995-04-04 Toyobo Co Ltd 抗炎症性、免疫抑制性および鎮痛性組成物、およびこれらの組成物を用いた自己免疫疾患の治療方法
EP0619116A3 (en) * 1993-04-05 1994-11-23 Hoechst Japan Use of synthetic retinoids for osteopathy.
GB2311009B (en) * 1996-03-06 2000-01-26 Mohd Taufiq Khan Pharmaceutical compositions containing tagetes plants
JPH10194917A (ja) * 1997-01-14 1998-07-28 Noevir Co Ltd 抗菌性低刺激化粧料
US20070020724A1 (en) * 1998-06-16 2007-01-25 Ruben Steven M 94 human secreted proteins
US6479545B1 (en) 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
RO120121B1 (ro) * 2000-12-18 2005-09-30 Elena Ionaşcu Soluţie injectabilă, cu efect antiinflamator, procedeu de obţinere şi metodă de tratament a bolilor autoimune
JP2002193733A (ja) * 2000-12-25 2002-07-10 Kanebo Ltd 化粧料
US20030203843A1 (en) * 2001-04-20 2003-10-30 Pena Carol E. A. Proteins and nucleic acids encoding same
CA2479732A1 (en) 2002-03-19 2003-10-02 Curagen Corporation Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003092666A1 (en) * 2002-05-01 2003-11-13 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Calcium-containing tissue strengthening agents and use thereof
JP2005126327A (ja) * 2003-10-21 2005-05-19 Pola Chem Ind Inc 化粧崩れ防止化粧料
WO2006032091A2 (en) * 2004-09-21 2006-03-30 Lavender Hill Projects Pty Ltd Herbal composition

Also Published As

Publication number Publication date
US8337910B2 (en) 2012-12-25
MX2009010713A (es) 2009-12-15
WO2008123970A1 (en) 2008-10-16
US20110076345A1 (en) 2011-03-31
US20080241277A1 (en) 2008-10-02
US7871648B2 (en) 2011-01-18
JP2010523563A (ja) 2010-07-15

Similar Documents

Publication Publication Date Title
Biggin et al. Long-term bisphosphonate therapy in osteogenesis imperfecta
JP5984674B2 (ja) サイトカインアンタゴニスト及びコルチコステロイドを有する併用製剤
TW201442715A (zh) 用於加速骨骼生長之非晶形碳酸鈣
KR20210040171A (ko) 1회당 100∼200 단위의 ｐｔｈ가 주 1회 투여되는 것을 특징으로 하는, ｐｔｈ 함유 골다공증 치료/예방제
JP5374491B2 (ja) 骨折および骨欠損の処置のためのハーブ製剤
TWI344367B (en) Use of zoledronic acid or a pharmaceutically acceptable salt or hydrate thereof in the preparation of a medicament for the treatment of osteoporosis post hip fracture
Phillips et al. Massive osteolysis (phantom bone, disappearing bone): report of a case with mandibular involvement
Triantafyllopoulos et al. EMAS position statement: the management of postmenopausal women with vertebral osteoporotic fracture
JP4652689B2 (ja) 骨再生を促進するカルモジュリンの使用
CN103446513B (zh) 一种治疗骨折术后不愈合症的药物
CN100484538C (zh) 上、中、下部汤及其制备方法
Somankar et al. Management of Multiple Fractures in a Preadolescent With Osteogenesis Imperfecta Types III-IV
CN100562336C (zh) 活血丹及其制备方法
Wei et al. Artificial tiger bone powder for improving the quality of life in elderly patients with fracture
Benny et al. Effective management of Colles fracture using Murivenna and Abha Guggulu–A case report
CN101904958A (zh) 治疗骨折的口服药组合物
RU2416411C2 (ru) Способ лечения переломов длинных трубчатых костей
RU2155588C2 (ru) Способ увеличения массы костной ткани при переломах
Moon et al. An uncommon case of bilateral pathologic hip fractures: antiviral drug-induced osteomalacia in a patient with hepatitis B
CN115251339B (zh) 一种通过调节肠道菌群增加骨密度的功能食品组合物及其制备方法
Rugpolmuang et al. Effect of a short-term treatment with once-a-week medication of alendronate 70 Mg on bone turnover markers in postmenopausal women with osteoporosis
Rizvi et al. Paget’s Disease of Bone: A Rare Incidence in Early Adult Life in Pakistan, Southeast Asia
Grześkowiak et al. Use of Ursodeoxycholic Acid (UDCA) in the Prevention of Gallstone Disease After Bariatric Surgery–A Literature Review
CN120459186A (zh) 一种治疗骨折的中药组合物及其制备方法
Zhu et al. Zuogui Pill Combined with Calcium versus Alendronate Combined with Calcium in Patients with Diabetes Induced Abnormal Bone Metabolism: An Efficacy and Safety Analysis

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110329

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110329

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130219

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130515

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130522

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130606

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130613

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130708

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130716

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130816

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130910

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130920

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees